UAB "B-link pharma" Finance - revenue, profit
UAB "B-link pharma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 20,150,492 |
| 1,355,110 |
| 617,400 |
| 545,088 |
| 36,657 |
| 7.78 |
| 2.71 |
| 2,783,881 |
| 1,331,353 |
| 782,672 |
| 3,315,097 |
| 2023 |
|---|
| 18,778,940 |
| 1,292,425 |
| 632,115 |
| 539,129 |
| 37,105 |
| 9.70 |
| 2.87 |
| 3,170,069 |
| 911,445 |
| 735,384 |
| 3,346,409 |
| 2024 |
|---|
| 16,143,118 |
| 986,140 |
| 318,505 |
| 261,626 |
| 15,982 |
| 9.16 |
| 1.62 |
| 3,363,030 |
| 800,957 |
| 814,807 |
| 3,365,410 |
Register and
explore Okredo data| 2024 |
|---|
| 16,143,118 |
| 986,140 |
| 318,505 |
| 261,626 |
| 15,982 |
| 9.16 |
| 1.62 |
| 3,363,030 |
| 800,957 |
| 814,807 |
| 3,365,410 |
Register and
explore Okredo data2024
Turnover (€)
16,143,118 €
-14 % *
Sales per employee (€)
986,140 €-24 % *
Profit before tax (€)
318,505 €-50 % *
Net Profit (€)
261,626 €-51 % *
Profit per employee (€)
15,982 €-57 % *
Total profitability (%)
9.16 %-5.57 % *
Net profitability (%)
1.62 %-43.55 % *
Equity (€)
3,363,030 €
6 % *
Amounts Payable And Liabilities (€)
800,957 €
-12 % *
Non-current Assets (€)
814,807 €
11 % *
CurrentAssets (€)
3,365,410 €1 % *